These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 29179482)
1. Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma. Wang D; Du L; Wang Z; Liu X; Qin Y; Wang Q; Yang Z; Yao Z; Shi M; Shang B; Jia Y; Chen H; Qiao L; Wang X; Xiao Z; Liu Z Oncotarget; 2017 Oct; 8(51):88857-88869. PubMed ID: 29179482 [TBL] [Abstract][Full Text] [Related]
2. High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients. Song Q; Liu Y; Jiang D; Wang H; Huang J; Xu Y; Sujie A; Zeng H; Xu C; Hou Y Oncotarget; 2017 Sep; 8(43):74539-74553. PubMed ID: 29088806 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer. Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986 [TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of Kwon D; Yun JY; Keam B; Kim YT; Jeon YK World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma. Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Jung DH; Shin SK; Lee SK; Lee YC; Kim HR; Moon YW; Kim JH; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC Oncotarget; 2015 Feb; 6(4):2562-72. PubMed ID: 25537505 [TBL] [Abstract][Full Text] [Related]
6. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573 [TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of Wang Y; Wu Y; Li J; Lai Y; Zhou K; Che G Ann Transl Med; 2019 Nov; 7(22):669. PubMed ID: 31930070 [TBL] [Abstract][Full Text] [Related]
8. FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer. Seo AN; Jin Y; Lee HJ; Sun PL; Kim H; Jheon S; Kim K; Lee CT; Chung JH Virchows Arch; 2014 Nov; 465(5):547-58. PubMed ID: 25086725 [TBL] [Abstract][Full Text] [Related]
9. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients. Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149 [TBL] [Abstract][Full Text] [Related]
10. Wang X; Ge X; Wang H; Huang J; Song Q; Xu C; Jiang Z; Su J; Wang H; Tan L; Jiang D; Hou Y Ann Transl Med; 2021 Feb; 9(4):321. PubMed ID: 33708948 [TBL] [Abstract][Full Text] [Related]
11. Association Between Fibroblast Growth Factor Receptor 1 Gene Amplification and Human Papillomavirus Prevalence in Tonsillar Squamous Cell Carcinoma With Clinicopathologic Analysis. Park S; Lee M; Cho KJ; Kim SB; Roh JL; Choi SH; Nam SY; Kim SY; Song JS J Histochem Cytochem; 2018 Jul; 66(7):511-522. PubMed ID: 29553868 [TBL] [Abstract][Full Text] [Related]
12. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients. Chen B; Liu S; Gan L; Wang J; Hu B; Xu H; Tong R; Yang H; Cristina I; Xue J; Hu X; Lu Y Cancer Biol Ther; 2018 Jan; 19(1):76-86. PubMed ID: 29257923 [TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of Fibroblast growth factor receptor 1 (FGFR1) gene amplification and protein overexpression in hypopharyngeal and laryngeal squamous cell carcinoma. Kim EK; Cho YA; Koh YW; Shin HA; Cho BC; Yoon SO BMC Cancer; 2020 Apr; 20(1):348. PubMed ID: 32326908 [TBL] [Abstract][Full Text] [Related]
14. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma. Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056 [TBL] [Abstract][Full Text] [Related]
15. Prevalence, morphology, and natural history of FGFR1-amplified lung cancer, including squamous cell carcinoma, detected by FISH and SISH. Russell PA; Yu Y; Young RJ; Conron M; Wainer Z; Alam N; Solomon B; Wright GM Mod Pathol; 2014 Dec; 27(12):1621-31. PubMed ID: 24762544 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma. Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643 [TBL] [Abstract][Full Text] [Related]
17. Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer. Guo K; Wang WP; Jiang T; Wang JZ; Chen Z; Li Y; Zhou YA; Li XF; Lu Q; Zhang LJ J Thorac Dis; 2016 Jul; 8(7):1753-63. PubMed ID: 27499966 [TBL] [Abstract][Full Text] [Related]
18. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma. Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558 [TBL] [Abstract][Full Text] [Related]
19. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer. Wang X; Cao L; Li S; Wang F; Huang D; Jiang R J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599 [No Abstract] [Full Text] [Related]
20. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma. Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]